KINRIX

NDC 58160-812, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine, injection, suspension, from GlaxoSmithKline Biologicals SA.

Product NDC: 58160-812
Status: Listed
Labeler: GlaxoSmithKline Biologicals SA
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Product type: VACCINE
Marketing category: BLA
Application: BLA125260
DEA schedule: None

Request

curl https://api.healthcare.dev/v1/drugs/ndc/58160-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)25 [iU]/.5mL
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)10 [iU]/.5mL
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)25 [iU]/.5mL
BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED)8 ug/.5mL
BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)25 ug/.5mL
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)40 [iU]/.5mL
POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)8 [iU]/.5mL
POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)32 [iU]/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Diphtheria Toxoid [CS]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Clostridium Tetani Vaccine [EPC]; Inactivated Corynebacterium Diphtheriae Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Poliovirus Vaccines [CS]; Poliovirus Vaccines [CS]; Poliovirus Vaccines [CS]; Tetanus Toxoid [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]

Package NDC	NDC-11	Package
58160-812-52	58160081252	10 SYRINGE in 1 CARTON (58160-812-52) / .5 mL in 1 SYRINGE (58160-812-43)

Linked data

RxNorm, label and prices

RxNorm concepts

8305570.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Kinrix] (SBD)

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58160-812 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/ndc/58160-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up NDC 58160-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Get a free key NDC docs Connect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.